Axon Enterprise, Inc. (NASDAQ:AXON) Shares Purchased by California State Teachers Retirement System

California State Teachers Retirement System lifted its position in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 1.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 116,206 shares of the biotechnology company’s stock after acquiring an additional 1,603 shares during the period. California State Teachers Retirement System’s holdings in Axon Enterprise were worth $36,359,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in the company. B. Riley Wealth Advisors Inc. lifted its position in Axon Enterprise by 24.4% during the first quarter. B. Riley Wealth Advisors Inc. now owns 6,266 shares of the biotechnology company’s stock worth $1,961,000 after buying an additional 1,229 shares in the last quarter. Bayesian Capital Management LP acquired a new position in shares of Axon Enterprise in the 1st quarter valued at $2,350,000. Zurich Insurance Group Ltd FI lifted its stake in shares of Axon Enterprise by 0.3% in the 1st quarter. Zurich Insurance Group Ltd FI now owns 201,183 shares of the biotechnology company’s stock valued at $62,946,000 after purchasing an additional 526 shares during the last quarter. BOKF NA lifted its stake in shares of Axon Enterprise by 52.7% in the 1st quarter. BOKF NA now owns 9,465 shares of the biotechnology company’s stock valued at $2,947,000 after purchasing an additional 3,268 shares during the last quarter. Finally, Hood River Capital Management LLC lifted its stake in shares of Axon Enterprise by 7.2% in the 1st quarter. Hood River Capital Management LLC now owns 213,724 shares of the biotechnology company’s stock valued at $66,870,000 after purchasing an additional 14,330 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON traded down $4.71 during trading hours on Wednesday, reaching $300.01. The stock had a trading volume of 662,140 shares, compared to its average volume of 487,403. The firm has a market cap of $22.64 billion, a price-to-earnings ratio of 87.72, a PEG ratio of 6.96 and a beta of 0.95. The company has a current ratio of 2.91, a quick ratio of 2.55 and a debt-to-equity ratio of 0.37. Axon Enterprise, Inc. has a fifty-two week low of $175.37 and a fifty-two week high of $329.87. The firm has a 50-day moving average of $295.17 and a 200-day moving average of $293.13.

Axon Enterprise (NASDAQ:AXONGet Free Report) last announced its earnings results on Friday, May 10th. The biotechnology company reported $1.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.95 by $0.20. Axon Enterprise had a return on equity of 11.71% and a net margin of 15.60%. The firm had revenue of $460.74 million during the quarter, compared to analysts’ expectations of $441.57 million. During the same period in the prior year, the firm earned $0.51 EPS. The business’s revenue was up 34.3% on a year-over-year basis. Equities research analysts predict that Axon Enterprise, Inc. will post 2.35 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages have recently commented on AXON. Bank of America began coverage on Axon Enterprise in a research note on Wednesday, July 17th. They issued a “buy” rating and a $380.00 price target on the stock. JPMorgan Chase & Co. boosted their price objective on Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a report on Thursday, April 11th. Needham & Company LLC reiterated a “buy” rating and issued a $400.00 price objective on shares of Axon Enterprise in a report on Tuesday, May 7th. JMP Securities reiterated a “market outperform” rating and issued a $375.00 price objective on shares of Axon Enterprise in a report on Tuesday, May 7th. Finally, Jefferies Financial Group assumed coverage on Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $385.00 price objective on the stock. Two analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average price target of $342.54.

Read Our Latest Analysis on AXON

Insiders Place Their Bets

In other Axon Enterprise news, President Joshua Isner sold 44,000 shares of the stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $309.96, for a total transaction of $13,638,240.00. Following the completion of the sale, the president now directly owns 275,843 shares of the company’s stock, valued at approximately $85,500,296.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, President Joshua Isner sold 44,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $309.96, for a total value of $13,638,240.00. Following the completion of the sale, the president now directly owns 275,843 shares of the company’s stock, valued at approximately $85,500,296.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jeffrey C. Kunins sold 43,668 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $309.94, for a total value of $13,534,459.92. Following the completion of the sale, the insider now directly owns 189,719 shares of the company’s stock, valued at $58,801,506.86. The disclosure for this sale can be found here. In the last ninety days, insiders sold 89,447 shares of company stock valued at $27,684,677. 6.10% of the stock is owned by company insiders.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Read More

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.